The global Intravenous (IV) Solutions Market size is expected to grow significantly in the coming decade, from USD 7.8 billion in 2022 to USD 12.5 billion by 2032, with a projected Compound Annual Growth Rate (CAGR) of 4.8%. The rising prevalence of chronic diseases such as cancer and diabetes, coupled with an increasing geriatric population, are major factors driving the growth of the market....
English
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Română
Português
Ελληνικά
Tiếng Việt